PubMed Health⌕ Search

Biomedical subjects

P Guthrie

Publications and source records attributed to P Guthrie.

4 recordsLinked to original sources
PubMed1990

Categorical versus dimensional status of borderline personality disorder.

One of the many controversies concerning the borderline personality disorder (BPD) diagnosis is whether the construct refers to a categorical or dimensional variable. The current study used Meehl's (1973) maximum covariance analysis to investigate this issue. The charts of 409 psychiatric inpatients were systematically reviewed for the presence of BPD and dysthymic symptoms. Charts of 244 inpatients were also reviewed to assess the presence of indicators of male sex, a categorical variable. The results for BPD and dysthymia were consistent with a dimensional model, whereas those for male sex were consistent with a categorical model. A dimensional model of classification of BPD is recommended, and suggestions for future research are provided.

Adult↗
PubMed1985

Effect of dry matter intake from whole goat milk and calf milk replacer on performance of Nubian goat kids.

The dry matter in calf milk replacer was compared with dry matter in goat milk for Nubian goat kids. Kids were fed the following diets from 4 days of age for 6 wk: 1) whole goat milk (14.0% dry matter), 2) calf milk replacer (13.5% dry matter), and 3) calf milk replacer (18.0% dry matter). Body weight of kids fed whole milk and 18.0% dry matter milk replacer increased each week. Kids fed the 13.5% dry matter milk replacer increased in weight to the 3rd wk but steadily declined thereafter. Total weight gain was more for kids fed whole milk (3.89 kg) than for kids fed milk replacer diets with 13.5 or 18.0% dry matter (.79 and 3.06 kg, respectively). For the first 3 wk, average daily gain was lowest for kids fed 18.0% milk replacer diet, but highest for wk 4 to 6. These data indicate that 3-week-old goat kids can utilize large amounts of dry matter from milk replacer to sustain a rate of growth similar to that of kids fed whole milk; however, high amounts of dry matter from milk replacer are poorly utilized by kids during the first 3 wk of life.

Animal Feed↗
PubMed1976

Effect of cholecystokinin and 16,16-dimethyl prostaglandin E2 on RNA and DNA of gastric and duodenal mucosa.

Fasted rats were injected with either cholecystokinin-octopeptide (CCK-OP), 20 mug per kg; 16,16-dimethyl prostaglandin E2 (16,16-dimethyl PGE2), 0.2 mg per kg; pentagastrin, 250 mug per kg, or saline every 8 hr for 48 hr. The rats were killed and the incorporation of [3H]thymidine into DNA as well as the total DNA and RNA content of the mucosa of the oxyntic gland area and the duodenum were determined. Pentagastrin increased DNA synthesis 60% (P less than 0.001) in gastric mucosa and 90% (P less than 0.001) in duodenal mucosa when compared with rates for saline controls. Neither CCK-OP nor 16,16-dimethyl PGE2 altered gastric mucosal DNA synthesis. Pentagastrin significantly increased the DNA and RNA content of both the gastric and duodenal mucosa. CCK-OP and 16,16-dimethyl PGE2 caused a slight but significant increase in duodenal DNA synthesis, CCK-OP did not significantly increase duodenal DNA content, and 16,16-dimethyl PGE 2 increased duodenal RNA but not DNA content. CCK-OP (20 mug per kg) in combination with pentagastrin did not alter the stimulation of gastric DNA synthesis but significantly decreased the effect of pentagastrin on duodenal DNA. A dose of CCK-OP (370 mug per kg) equimolar to 250 mug per kg of pentagastrin did not stimulate DNA synthesis in either tissue and significantly inhibited stimulation by pentagastrin in both tissues. Low doses of CCK-OP (2.5, 5.0, 10.0, 20.0 mug per kg) caused statistically significant increases in DNA synthesis and DNA content of the pancreas, but had no effect on either mucosa of the oxyntic gland area or duodenum. 16,16-Dimethyl PGE2 did not inhibit the stimulation of DNA synthesis or the increases in DNA and RNA content stimulated by pentagastrin. From these results it appears that: (1) moderate doses of CCK have a weak trophic effect in the duodenum but not in the stomach, (2) physiological doses of CCK-OP stimulated pancreatic DNA synthesis and increased pancreatic DNA content without affecting these parameters in the oxyntic gland area or duodenum in the same animals, (3) in the stomach and duodenum CCK is not as potent a trophic hormone as gastrin and inhibits, probably competitively, the trophic effects of gastrin, (4) 16,16-dimethyl PGE2 does not stimulate growth and does not interfere with the trophic response to gastrin even though it inhibits acid secretion, and (5) 16,16-dimethyl PGE2 increased the RNA content of duodenal mucosa indicating that it may stimulate activity resulting in hypertrophy.

Animals↗